Zydus Lifesciences jumps on getting approval from COFEPRIS to market Mamitra

31 Jul 2024 Evaluate

Zydus Lifesciences is currently trading at Rs. 1242.90, up by 24.25 points or 1.99% from its previous closing of Rs. 1218.65 on the BSE.

The scrip opened at Rs. 1230.50 and has touched a high and low of Rs. 1248.60 and Rs. 1227.30 respectively. So far 19643 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1251.00 on 29-Jul-2024 and a 52 week low of Rs. 567.85 on 26-Oct-2023.

Last one week high and low of the scrip stood at Rs. 1251.00 and Rs. 1168.50 respectively. The current market cap of the company is Rs. 125064.82 crore.

The promoters holding in the company stood at 74.98%, while Institutions and Non-Institutions held 18.22% and 6.79% respectively.

Zydus Lifesciences has been granted marketing approval for Mamitra, a Trastuzumab biosimilar, by the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk). The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2 overexpressing metastatic breast cancer (MBC), HER2 overexpressing early breast cancer (EBC) and advanced gastric cancer. Breast cancer has become the most diagnosed cancer in Mexico, overtaking prostate and colorectal cancers.

Zydus had developed and launched the Trastuzumab biosimilar developed in-house by the research team at the Zydus Research Centre (ZRC) in 2016 in India under the brand name Vivitra. ?Since then, an estimated 1,00,000 patients have been treated with the therapy. With twelve lifesaving biosimilars already launched in the market, Zydus has been bridging the unmet need for affordable therapies in the fight against cancer in India.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.


Zydus Lifesciences Share Price

908.90 7.60 (0.84%)
31-Dec-2025 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.80
Dr. Reddys Lab 1261.80
Cipla 1493.00
Zydus Lifesciences 908.90
Lupin 2081.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×